These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2871091

  • 1. Teicoplanin in the treatment of infection caused by gram-positive organisms.
    Williams AH, Grüneberg RN, Webster A, Ridgway GL.
    J Hosp Infect; 1986 Mar; 7 Suppl A():101-3. PubMed ID: 2871091
    [Abstract] [Full Text] [Related]

  • 2. A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria.
    Lewis P, Garaud JJ, Parenti F.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():61-7. PubMed ID: 2965133
    [Abstract] [Full Text] [Related]

  • 3. Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA.
    LeFrock JL, Ristuccia AM, Ristuccia PA, Quenzer RW, Haggerty PG, Allen JE, Lettau LA, Schwartz R, Appleby D.
    Eur J Surg Suppl; 1992 Jan; (567):9-13. PubMed ID: 1381644
    [Abstract] [Full Text] [Related]

  • 4. Clinical efficacy and safety of teicoplanin in the treatment of gram-positive infections.
    Kempf P, Pompetzki H, Oppermann A, Wittenberger R, Siebert J, Fell JJ, Dieterich HA.
    Infection; 1989 Jan; 17(3):177-81. PubMed ID: 2525529
    [Abstract] [Full Text] [Related]

  • 5. Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin.
    Greenberg RN.
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2392-7. PubMed ID: 2150908
    [Abstract] [Full Text] [Related]

  • 6. Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study.
    Pauluzzi S, Del Favero A, Menichetti F, Baratta E, Moretti VM, Di Filippo P, Pasticci MB, Guerciolini R, Patoia L, Frongillo RF.
    J Antimicrob Chemother; 1987 Sep; 20(3):431-8. PubMed ID: 2960643
    [Abstract] [Full Text] [Related]

  • 7. Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts.
    Van der Auwera P, Aoun M, Meunier F.
    Antimicrob Agents Chemother; 1991 Mar; 35(3):451-7. PubMed ID: 1828134
    [Abstract] [Full Text] [Related]

  • 8. Teicoplanin in the treatment of infections by staphylococci, Clostridium difficile and other gram-positive bacteria.
    de Lalla F, Santoro D, Rinaldi E, Suter F, Cruciani M, Guaglianone MH, Rizzardini G, Pellegata G.
    J Antimicrob Chemother; 1989 Jan; 23(1):131-42. PubMed ID: 2526109
    [Abstract] [Full Text] [Related]

  • 9. Intravenous or intramuscular teicoplanin once daily for skin and soft-tissue infections.
    Edelstein HE, Oster SE, Chirurgi VA, Karp RA, Cassano KB, McCabe RE.
    DICP; 1991 Sep; 25(9):914-8. PubMed ID: 1835223
    [Abstract] [Full Text] [Related]

  • 10. Teicoplanin in the treatment of skin and soft tissue infections: results of a multicentre study.
    Lang E, Földes M, Marghescu S.
    Infection; 1991 Sep; 19(3):190-4. PubMed ID: 1832418
    [Abstract] [Full Text] [Related]

  • 11. Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria.
    Glupczynski Y, Lagast H, Van der Auwera P, Thys JP, Crokaert F, Yourassowsky E, Meunier-Carpentier F, Klastersky J, Kains JP, Serruys-Schoutens E.
    Antimicrob Agents Chemother; 1986 Jan; 29(1):52-7. PubMed ID: 2942100
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections.
    Bibler MR, Frame PT, Hagler DN, Bode RB, Staneck JL, Thamlikitkul V, Harris JE, Haregewoin A, Bullock WE.
    Antimicrob Agents Chemother; 1987 Feb; 31(2):207-12. PubMed ID: 2952062
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical efficacy and safety of teicoplanin.
    Stille W, Sietzen W, Dieterich HA, Fell JJ.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():69-79. PubMed ID: 2965134
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Teicoplanin--a new agent for gram-positive bacterial infections.
    Eggleston M, Ofosu J.
    Infect Control Hosp Epidemiol; 1988 May; 9(5):209-11. PubMed ID: 2967322
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of teicoplanin in gram-positive peritonitis in patients on peritoneal dialysis.
    Neville LO, Baillod RA, Brumfitt W, Hamilton-Miller JM.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():123-31. PubMed ID: 2965124
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.